Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Syneos Health Inc (NQ: SYNH )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Sep 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Syneos Health Inc

< Previous 1 2 3 4 5 6 7 8 Next >
Stocks That Hit 52-Week Lows On Thursday
  On Thursday, 529 companies set new 52-week lows. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
  
Via Benzinga
Syneos Health Stock Tanks After Q2 Sales Miss, FY22 Outlook Cut Citing Macro Economic Trends
Via Benzinga
Recap: Syneos Health Q2 Earnings
  Syneos Health (NASDAQ:SYNH) reported its Q2 earnings results on Tuesday, August 2, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Syneos Health Shares Jump On Better Than Expected Q1 Earnings, FY22 Outlook
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 238 companies achieved new lows for the year. 
Via Benzinga
Avis Budget, Zebra Technologies And Some Other Big Stocks Moving Lower On Tuesday
  FAT Brands Inc. (NASDAQ: FATBB) fell 30% to $10.50. The company recently posted a Q2 net loss of $8.2 million or $0.50 per share. 
Via Benzinga
Syneos Health: Q1 Earnings Insights
Syneos Health (NASDAQ:SYNH) reported its Q1 earnings results on Friday, April 29, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Why Shares Of Cannabis Companies Traded Higher; Here Are 101 Biggest Movers From Yesterday
Gainers MMTec, Inc. (NASDAQ: MTC) shares gained 390.6% to close at $7.85 on Tuesday amid volatility in nano-cap Chinese stocks. 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low. 
Via Benzinga
Recap: Syneos Health Q4 Earnings
  Syneos Health (NASDAQ:SYNH) reported its Q4 earnings results on Thursday, February 17, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Why Applied DNA Sciences Is Trading Higher By 166%, Here Are 75 Stocks Moving In Tuesday's Mid-Day Session
Gainers AMTD IDEA Group (NYSE: AMTD) shares jumped 284% to $8.00 after jumping 18% on Monday. The company owns 90%+ of AMTD Digital. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
  
Via Benzinga
Earnings Scheduled For February 17, 2022
Companies Reporting Before The Bell • Palantir Technologies (NYSE:PLTR) is estimated to report quarterly earnings at $0.04 per share on revenue of $417.69 million. 
Via Benzinga
Analyst Ratings For Syneos Health
Within the last quarter, Syneos Health (NASDAQ:SYNH) has observed the following analyst ratings: 
Via Benzinga
Earnings Scheduled For August 2, 2022
Companies Reporting Before The Bell • Ferrari (NYSE:RACE) is expected to report quarterly earnings at $1.27 per share on revenue of $1.22 billion. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2022
Upgrades 
Via Benzinga
Syneos Health's Return On Capital Employed Insights
Pulled from Benzinga Pro data, Syneos Health (NASDAQ:SYNH) posted Q1 earnings of $46.18 million, an increase from Q4 of 39.21%. Sales dropped to $1.34 billion, a 2.69% decrease between quarters. 
Via Benzinga
A Preview Of Syneos Health's Earnings
Syneos Health (NASDAQ:SYNH) is set to give its latest quarterly earnings report on Friday, 2022-04-29. Here's what investors need to know before the announcement. Analysts estimate that Syneos Health... 
Via Benzinga
Earnings Scheduled For April 29, 2022
Companies Reporting Before The Bell • Weyerhaeuser (NYSE:WY) is projected to report quarterly earnings at $1.19 per share on revenue of $2.93 billion. 
Via Benzinga
Looking Into Syneos Health's Return On Capital Employed
Pulled from Benzinga Pro data, Syneos Health (NASDAQ:SYNH) showed a loss in earnings since Q3, totaling $75.96 million. Sales, on the other hand, increased by 1.84% to $1.37 billion during Q4. 
Via Benzinga
The Daily Biotech Pulse: J&J Unit Announces Research Collaboration With Remix, Regencell Touts COVID Data, Decision Day For Agios
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Amylyx's ALS Treatment Regulatory Application To Be Reviewed By FDA Panel... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 25, 2022
Via Benzinga
Syneos Health Reports Mixed Q4 Earnings, Provides FY22 Guidance
Syneos Health Inc's (NASDAQ: SYNH) Q4 revenue increased 20.5% on a reported basis and 20.8% on a constant currency (CC) basis to  
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 12, 2022
Upgrades 
Via Benzinga
Labcorp In Talks To Merge Some Covance Assets With Syneos: Bloomberg
Laboratory Corp of America Holdings (NYSE: LH) is in talks to combine some of its assets with Syneos Health Inc (NASDAQ: SYNH), reports Bloomberg citing... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2021
Upgrades B of A Securities upgraded the previous rating for ONE Gas Inc (NYSE: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 5, 2021
Upgrades For IGM Biosciences Inc (NASDAQ: 
Via Benzinga
Syneos Health, inc (SYNH) Q3 2021 Earnings Call Transcript
SYNH earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Syneos Health's Return On Capital Employed Overview
According to Benzinga Pro, during Q3, Syneos Health (NASDAQ:SYNH) earned $113.36 million, a 35.46% increase from the preceding quarter. Syneos Health also posted a total of $1.35... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.